Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading ->